A whole blood flow cytometric determination of platelet activation by unfractionated and low molecular weight heparin in vitro

被引:13
作者
Klein, B
Faridi, A
von Tempelhoff, GF
Heilmann, L
Mittemayer, C
Rath, W
机构
[1] Univ Technol, Univ Hosp, Rhein Westfal TH Aachen, Dept Gynecol & Obstet, D-52074 Aachen, Germany
[2] City Hosp Ruesselsheim, Dept Gynecol & Obstet, Russelsheim, Germany
[3] Univ Technol, Univ Hosp, Rhein Westfal TH Aachen, Inst Pathol, D-52074 Aachen, Germany
关键词
heparin; platelets; thrombocytopenia; flow cytometry; whole blood; low molecular weight heparin;
D O I
10.1016/S0049-3848(03)00094-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The influence of unfractionated (Heparin-Natrium) and low-molecular heparin (Fragmin(R)) on platelet activation in whole blood was investigated by FACS analysis in vitro using antibodies against glycoprotein (gp) lII/IIIa (CD 41), GMP 140 (CD 62P), gp 53 (CD 63) and fibrinogen. Samples were also labeled with anti-gp Ib (CD 42b). Neither unfractionated heparin (UFH) nor low molecular weight heparin (LMWH) led to significant (i.e.,p<0.05) changes in fluorescence intensities of platelets labeled with anti-gp IIb/IIIa or anti-gp 53. Significant platelet activation due to unfractionated heparin could be observed by labeling with anti-GMP 140 (UFH: p = 0.009; LMWH: p = 0.16). The proportion of platelets with surface-bound fibrinogen was significantly increased (UFH:p = 0.00006; LMWH: p = 0.008). After incubation with heparins, activation ability of platelets by adenosine diphosphate (ADP) was significantly increased. The potentiating action of unfractionated heparin was larger. Therefore, flow cytometric results of platelet activation in patients receiving heparin should be interpreted carefully. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 28 条
[1]   HEPARIN-INDUCED PLATELET-AGGREGATION - DOSE-RESPONSE RELATIONSHIPS FOR A LOW-MOLECULAR-WEIGHT HEPARIN DERIVATIVE (PK-10169) AND ITS SUBFRACTIONS [J].
BRACE, LD ;
FAREED, J .
THROMBOSIS RESEARCH, 1986, 42 (06) :769-782
[2]   EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN ON PLATELETS AS COMPARED WITH COMMERCIAL HEPARIN [J].
CELLA, G ;
SCATTOLO, N ;
LUZZATTO, G ;
GIROLAMI, A .
RESEARCH IN EXPERIMENTAL MEDICINE, 1984, 184 (04) :227-229
[3]   Three new diterpenoids from Mallotus apelta Muell.Arg. [J].
Cheng, XF ;
Chen, ZL .
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 1999, 1 (04) :319-325
[4]  
CHONG BH, 1989, EUR J HAEMATOL, V43, P245
[5]   HEPARIN-INDUCED THROMBOCYTOPENIA [J].
CHONG, BH .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1992, 22 (02) :145-152
[6]  
DUNN FW, 1984, NOUV REV FR HEMATOL, V26, P249
[7]  
EIKA C, 1972, SCAND J HAEMATOL, V9, P665
[8]   PLATELET-AGGREGATION FOLLOWING HEPARIN AND PROTAMINE ADMINISTRATION [J].
ELLISON, N ;
EDMUNDS, LH ;
COLMAN, RW .
ANESTHESIOLOGY, 1978, 48 (01) :65-68
[9]  
HEINRICH D, 1988, HAEMOSTASIS, V18, P48
[10]  
JANES SL, 1993, THROMB HAEMOSTASIS, V70, P659